Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

The Company expects to submit a New Drug Application to the Food and Drug Administration in the third quarter of 2025.

Chugai Pharma seeks Japanese additional indication approval for Tecentriq to treat thymic carcinoma: Tokyo Thursday, May 15, 2025, 12:00 Hrs [IST] Chugai Pharmaceutical Co., Ltd., ...

A panelist discusses how guidelines from organizations like the National Comprehensive Cancer Network (NCCN) can improve ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...